Evidence map›Paper›PMID 28542510›Full record

ArticlePloS one2017

Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis.

Hirokazu Honda, Tsutomu Hirano, Masashi Ueda, Shiho Kojima, Shinichi Mashiba, Yasuyuki Hayase, Tetsuo Michihata, Kanji Shishido, Keiko Takahashi, Nozomu Hosaka and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Cardiovascular risk factors in children on dialysis: an update.Pediatric nephrology (Berlin, Germany) · 2020
    Review
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Hirokazu HondaDivision of Nephrology, Department of Medicine, Showa University Koto Toyosu Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0002-5634-6145
Tsutomu HiranoDivision of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Masashi UedaIkagaku, Research Development, Kyoto, Japan.
Shiho KojimaIkagaku, Research Development, Kyoto, Japan.
Shinichi MashibaIkagaku, Research Development, Kyoto, Japan.
Yasuyuki HayaseIkagaku, Research Development, Kyoto, Japan.
Tetsuo MichihataDepartment of Dialysis, Ebara Clinic, Tokyo, Japan.
Kanji ShishidoDepartment of Dialysis, Kawasaki Clinic, Kawasaki, Japan.
Keiko TakahashiDivision of Dialysis, Kitami Higashiyama Clinic, Tokyo, Japan.
Nozomu HosakaDivision of Nephrology, Department of Medicine, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Misa IkedaDivision of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Daisuke SanadaDivision of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Takanori ShibataDivision of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Showa University · JPEbara (Japan) · JPKawasaki Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apolipoproteins are associated with survival among patients on hemodialysis (HD), but these associations might be influenced by dysfunctional (oxidized) high-density lipoprotein (HDL). We assessed associations among apolipoproteins and oxidized HDL, mortality and cardiovascular disease (CVD) events in patients on HD. This prospective observational study examined 412 patients on prevalent HD. Blood samples were obtained before dialysis at baseline to measure lipids, apolipoproteins, oxidized LDL, oxidized HDL, high-sensitivity C-reactive protein (hs-CRP) and interleukin (IL)-6 at baseline, and HDL-C and hs-CRP were measured 12 months later. Patients were then prospectively followed-up (mean, 40 months) and all-cause mortality and composite CVD events were analyzed. Associations between variables at baseline and clinical outcome were assessed by Cox proportional hazards modeling (n = 412) and Cox hazards modeling with a time-varying covariate with HDL-C and hs-CRP (n = 369). Quartiles of apolipoproteins and oxidized HDL were not associated with all-cause mortality. However, Cox proportional hazards models with quartiles of each variable adjusted for confounders and hs-CRP or IL-6 identified apolipoprotein (apo)B-to-apoA-I ratio (apoB/apoA-I) and oxidized HDL, but not apoA-I or apoA-II, as independent risk factors for composite CVD events. These associations were confirmed by Cox proportional hazards modeling with time-varying covariates for hs-CRP. ApoB/apoA-I was independently associated with composite CVD events in 1-standard deviation (SD) increase-of-variables models adjusted for the confounders, oxidized HDL and hs-CRP. However, these associations disappeared from the model adjusted with IL-6 instead of hs-CRP, and oxidized HDL and IL-6 were independently associated with composite CVD events. Findings resembled those from Cox proportional hazards modeling using time-varying covariates with HDL-C adjusted with IL-6. In conclusion, both oxidized HDL and apoB/apoA-I might be associated with CVD events in patients on prevalent HD, while associations of apoB/apoA-I with CVD events differed between models of apoB/apoA-I quartiles and 1-SD increases, and were influenced by IL-6.

Indexed as

Renal DialysisAdultAgedAged, 80 and overApolipoproteinsCardiovascular DiseasesC-Reactive ProteinFemaleFollow-Up StudiesHumansInterleukin-6LipidsLipoproteins, HDLLipoproteins, LDLMaleMiddle AgedApolipoproteinsC-Reactive ProteinInterleukin-6LipidsLipoproteins, HDLLipoproteins, LDLoxidized low density lipoprotein

Identifiers

PMID28542510
PMCPMC5436869
OpenAlexW2615269363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.